1)Hashimoto thyroiditis桥本甲状腺炎
1.The efficacy and safety of Intrathyroidal injection of dexamethasone and cyclophosphamide on Hashimoto thyroiditis;甲状腺内注射地塞米松和环磷酰胺治疗桥本甲状腺炎
2.IL-12, IL-10 and Hashimoto thyroiditis;IL-12及IL-10在桥本甲状腺炎发病机制中作用的研究进展
3.Expression of costimulatory molecules in thyroid tissue from patients with Hashimoto thyroiditis;桥本甲状腺炎甲状腺组织中共刺激分子的表达
英文短句/例句
1.Hashimoto toxicosis桥本甲状腺炎伴甲状腺毒症
2.Expression of Cx43 in thyroid epithelial cells from the patients with Hashimoto diseaseCx43在桥本甲状腺炎甲状腺上皮细胞中的表达
3.Expression of Cx26 in Thyroid Epithelial Cells from the Patients with Hashimoto DiseaseCx26在桥本甲状腺炎甲状腺上皮细胞中的表达
4.Exploration of ultrasonography in diagnosis of thyroid carcinoma with Hashimoto's thyroiditis桥本甲状腺炎背景下甲状腺癌的超声表现探讨
5.Expressions of interleukin-17 in thyroid tissue in patients with Hashimoto thyroiditisIL-17在桥本甲状腺炎甲状腺组织中的表达研究
6.Diagnostic Value of High-frequency Ultrasonography in Hashimoto's Thyroiditis高频超声对桥本甲状腺炎的诊断价值
7.The Immunohistochemic Expression of DACH1 and Its Clinical Significance in Papillary Thyroid Carcinoma and Hashimoto's ThyroiditisDACH1蛋白在甲状腺乳头状癌和桥本甲状腺炎中的表达
8.Effect Oral Levothyroxine Plus Intrathyroidal Injection of Dexamethasone on Conversion of Subclinical Hypothyroidism and Overt Hypothyroidism Caused by Hashimoto s Thyroidis;口服甲状腺素联合甲状腺内注射地塞米松治疗伴亚临床甲减和临床甲减的桥本甲状腺炎
9.Immunohistochemical Studies of TRAIL and Caspase-3 in Hashimoto s Hyroiditis;桥本甲状腺炎中TRAIL、Caspase-3的免疫组化研究
10.Effects of 1,25-Dihydroxyvitamin D3 on Cytokines Secreted from Th1/Th2 in Hanshmoto s Disease;Vit D_3对桥本甲状腺炎患儿Th1/Th2细胞因子的影响
11.The study on ralationship between apoptosis and proliferation in Hashimoto s thyroiditis;桥本甲状腺炎中细胞凋亡与增殖关系的研究
12.These well-differentiated cancers may be TSH-dependent and may develop in goiters secondary to Hashimoto's thyroiditis..这些高分化癌属TSH（促甲状腺激素）依赖型，可以在继发于桥本甲状腺炎的甲状腺肿中发展。
13.Thyroid hormone resistance with H435L mutation in exon 10 of thyroid hormone receptor β gene associated with Hashimoto's thyroiditis甲状腺激素受体β基因第10外显子H435L突变致甲状腺激素抵抗并桥本甲状腺炎
14.The expression and analysis of 2 dimensions and colour doppler sonography in Hashimoto thyroiditis桥本甲状腺炎的二维及彩色多普勒超声表现与分析
15.Expression and its significance of galectin-3,cytokeratin 19 and cytokeratin 7 in atypical thyrocytes of Hashimoto′s thyroiditis significance桥本甲状腺炎不典型细胞群Galectin-3、CK19、CK7的表达及意义
16.Genotypes of killer cell immunoglobulin-like receptors in Hashimoto′s thyroiditis patients桥本甲状腺炎患者杀伤细胞免疫球蛋白样受体基因型分析
17.Clinical value of serum IL-10,IL-12 and relative index level changed in children with Hashimoto thyroiditis儿童桥本甲状腺炎IL-10和IL-12及相关指标变化的临床价值
18.A PRELIMINARY STUDY ON EXPRESSION OF PDCD5 IN PATIENTS WITH GRAVES DISEASE AND HASHIMOTO'S THYROIDITIS程序性死亡因子5在Graves病和桥本甲状腺炎中表达的初步研究
相关短句/例句
Hashimoto's disease (HD)桥本甲状腺炎(HD)
3)Hashimoto's thyroiditis (HT)桥本甲状腺炎(HT)
4)Hashimoto's thyroiditis桥本氏甲状腺炎
5)Hashimoto's hyperthyroidism甲亢型桥本甲状腺炎
1.Significance of tests of thyroid autoantibodies in differential diagnosis between Hashimoto′s hyperthyroidism and Graves disease;甲状腺自身抗体检测在甲亢型桥本甲状腺炎和Graves病鉴别诊断中的意义
6)Hashimoto thyroiditis (HT)桥本氏甲状腺炎(HT)
延伸阅读
干甲状腺 ,甲状腺粉药物名称：甲状腺粉英文名：Powered Thyroid别名： 干甲状腺 ,甲状腺粉 外文名：Powdered Thyroid Gland适应症： 临床上主要用于治疗呆小病、粘液性水肿及其它甲状腺功能减退症等。 用量用法： 用于粘液性水肿：开始时口服１日不超过１５～３０ｍｇ，以后逐渐增加至１日９０～１８０ｍｇ。病情稳定后，改用维持量，每日６０～１２０ｍｇ，选用一个适合于长期应用的剂量。对呆小病：剂量随年龄而异，１岁以内１日８～１５ｍｇ，１～２岁为２０～４５ｍｇ，２岁以上为３０～１２０ｍｇ，均分３次服用。单纯性甲状腺肿：开始１日６０ｍｇ，逐渐增至１日１２０～１６０ｍｇ，疗程一般为３～６个月。 注意事项： 1.长期过量可引起甲状腺功能亢进的临床表现，如心悸、手震颤、多汗、体重减轻、神经兴奋性升高和失眠。在老年人和心脏病者可发生心绞痛和心肌梗塞。可用β受体阻断药对抗，并立即停用本品。 2.可与苯妥英钠、乙酰水杨酸，双香豆素类及口服降血糖药与血浆蛋白产生竞争性结合，增加这些药物在血浆中的游离量，从而增强其作用，加重不良反应，甚至发生意外，需特别注意。 3.糠尿病、冠心病等病人忌用。 规格： 片剂：每片１０ｍｇ、４０ｍｇ、６０ｍｇ。 类别：甲状腺用药
